Stock info Atricure | Filter  Basic-Info

Atricure

The past year was a good year for Atricure investors

Over the past year the company' stock lost around 16 percent. Over the period 2011-2016 the stock rose a massive 58,23 percent. Atricure's revenues between 2011 and 2015 were very fluctuating and moved between 70,25 million dollars and 129,76 million dollars. Atricure's net results between 2011 and 2015 were very fluctuating and moved between -5,46 million dollars and -27,21 million dollars.

Atricure's headquarter is located in West Chester. Atricure is active in the health care eq. & services sector. Mr. Michael H. Carrel is the company' CEO. Atricure has Mr. M. Andrew Wade CPA as CFO financial responsible for the company. Between 2006 and 2016 the global health care companies gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

The American company didn't pay out any dividends (in the past 5 years).

Atricure financed with relatively low debt

At the end of 2015 the American company's balance sheet was worth 273,09 million dollars. 86,4 million dollars (31,64 percent of the total balance sheet) was financed by debt. The American company's price/earnings-ratio was -21. So the market valued the stock at -21 times the 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 619,52 million dollars. At the end of 2015 the American company had around 28,06 million stocks listed.

All Atricure's financial reports are available here. More information about Atricure can be found it's website. .